The abstract, Phase 1 Dose-Escalation Study of Next-Generation Nectin-4 Targeting Antibody-Drug Conjugate CRB-701 (SYS6002) in US And UK Patients with Urothelial Cancer and other Solid Tumors ( Perez, ...
HAYWARD, CALIFORNIA / ACCESS Newswire / February 12, 2025 / Biolog, Inc., a leading provider of cell-based microbial and phenotypic profiling products and multi ...
Axtria Inc., a global cloud software and data analytics company for the life sciences industry, announces groundbreaking ...
NASHVILLE, Tenn., Feb. 12, 2025 /PRNewswire/ -- Clearsense ®, a cloud-based data enablement platform company, has unveiled a ...
The Canada Revenue Agency (CRA) has officially confirmed that Registered Clinical Counsellors (RCCs) in BC are now exempt from collecting GST on psychotherapy services. The ruling impacts 8,000+ RCCs, ...
Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption ...
A federal judge ordered health agencies Tuesday to reinstate certain webpages taken down in response to President Donald ...
Anticipates Late Filing of Annual Financial Statements - VANCOUVER, BC, Feb. 13, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") ...
Operator Thank you for standing by, and welcome to Amwell's fourth quarter 2024 earnings conference call. At this time, all ...
The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.
American Well Corporation ( NYSE: AMWL) Q4 2024 Earnings Conference Call February 12, 2025 5:00 PM ET Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman & Chief Executive Officer Mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results